239 related articles for article (PubMed ID: 25820698)
21. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis of 4,5-diazafluorene derivatives and their anticancer activity via targeting telomeric DNA G-quadruplex.
Zhou K; Liu J; Xiong X; Cheng M; Hu X; Narva S; Zhao X; Wu Y; Zhang W
Eur J Med Chem; 2019 Sep; 178():484-499. PubMed ID: 31202994
[TBL] [Abstract][Full Text] [Related]
23. Ligand Selectivity in the Recognition of Protoberberine Alkaloids by Hybrid-2 Human Telomeric G-Quadruplex: Binding Free Energy Calculation, Fluorescence Binding, and NMR Experiments.
Deng N; Xia J; Wickstrom L; Lin C; Wang K; He P; Yin Y; Yang D
Molecules; 2019 Apr; 24(8):. PubMed ID: 31010072
[TBL] [Abstract][Full Text] [Related]
24. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
[TBL] [Abstract][Full Text] [Related]
26. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
[TBL] [Abstract][Full Text] [Related]
27. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
[TBL] [Abstract][Full Text] [Related]
28. The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells.
Shen FH; Jin J; Li J; Wang Y; Zhu SH; Lu YJ; Ou TM; Huang ZS; Huang M; Huang ZY
Pharm Biol; 2013 Apr; 51(4):447-54. PubMed ID: 23363047
[TBL] [Abstract][Full Text] [Related]
29. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
31. Effects of a halogenated G-quadruplex ligand from the pyridine dicarboxamide series on the terminal sequence of XpYp telomere in HT1080 cells.
Sidibe A; Hamon F; Largy E; Gomez D; Teulade-Fichou MP; Trentesaux C; Riou JF
Biochimie; 2012 Dec; 94(12):2559-68. PubMed ID: 22796264
[TBL] [Abstract][Full Text] [Related]
32. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of novel quindoline derivatives with fork-shaped side chains as RNA G-quadruplex stabilizers for repressing oncogene NRAS translation.
Sun JW; Zou J; Zheng Y; Yuan H; Xie YZ; Wang XN; Ou TM
Eur J Med Chem; 2024 May; 271():116406. PubMed ID: 38688064
[TBL] [Abstract][Full Text] [Related]
34. Phenanthroline-2,9-bistriazoles as selective G-quadruplex ligands.
Nielsen MC; Larsen AF; Abdikadir FH; Ulven T
Eur J Med Chem; 2014 Jan; 72():119-26. PubMed ID: 24361524
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes.
Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW
Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049
[TBL] [Abstract][Full Text] [Related]
36. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Folini M; Pivetta C; Zagotto G; De Marco C; Palumbo M; Zaffaroni N; Sissi C
Biochem Pharmacol; 2010 Jun; 79(12):1781-90. PubMed ID: 20206144
[TBL] [Abstract][Full Text] [Related]
37. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents.
Sidoryk K; Świtalska M; Jaromin A; Cmoch P; Bujak I; Kaczmarska M; Wietrzyk J; Dominguez EG; Żarnowski R; Andes DR; Bańkowski K; Cybulski M; Kaczmarek Ł
Eur J Med Chem; 2015 Nov; 105():208-19. PubMed ID: 26496013
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of disubstituted amidoxanthones as potential telomeric G-quadruplex DNA-binding and apoptosis-inducing agents.
Shen R; Chen Y; Li Z; Qi H; Wang Y
Bioorg Med Chem; 2016 Feb; 24(4):619-26. PubMed ID: 26740156
[TBL] [Abstract][Full Text] [Related]
39. Trigeminal star-like platinum complexes induce cancer cell senescence through quadruplex-mediated telomere dysfunction.
Zheng XH; Mu G; Zhong YF; Zhang TP; Cao Q; Ji LN; Zhao Y; Mao ZW
Chem Commun (Camb); 2016 Dec; 52(98):14101-14104. PubMed ID: 27858019
[TBL] [Abstract][Full Text] [Related]
40. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
